Intrinsiqq
Sotera Health Company logo

Sotera Health Company (SHC) Insider Trading

Last 12 months

Insiders sold $36.3M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Executive Chairman Michael B. Petras Jr. sold $21.2M on Aug 17, 21% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market
−$36.3M
0 buys · 3 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
None
in the last two years

Get an email when SHC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 17No plan
    Michael B. Petras Jr.
    Executive Chairman · sold 1,144,515 at avg $18.50
    $21.2M
    21% of stake
  • Aug 7No plan
    Michael P Rutz
    President of Sterigenics · sold 150,000 at $18.84
    $2.83M
    31% of stake
  • May 13No plan
    Warburg Pincus (cayman) XI, L.p.
    Large holder · sold 19,102,952 at $15.17
    $290M
    100% of stake
  • May 13No plan
    Warburg Pincus XI, L.p.
    Large holder · sold 19,102,952 at $15.17
    $290M
    100% of stake
  • May 13No plan
    Gtcr Fund Xi/c LP
    Large holder · sold 12,735,301 at $15.17
    $193M
    100% of stake
  • Mar 6No plan
    Warburg Pincus Partners GP LLC
    Large holder · sold 15,000,000 at $15.27
    $229M
    44% of stake
  • Mar 6No plan
    Warburg Pincus Partners II, L.p.
    Large holder · sold 15,000,000 at $15.27
    $229M
    44% of stake
  • Mar 6No plan
    Gtcr Co-Invest XI LP
    Large holder · sold 10,000,000 at $15.27
    $153M
    44% of stake
  • Dec 8, 2025No plan
    Michael B. Petras Jr.
    Chairman & CEO · sold 750,000 at avg $16.45
    $12.3M
    12% of stake
  • Dec 3, 2025No plan
    Warburg Pincus LLC
    Large holder · sold 9,720,000 at $16.33
    $159M
    22% of stake
  • Dec 3, 2025No plan
    Warburg Pincus Partners GP LLC
    Large holder · sold 9,720,000 at $16.33
    $159M
    22% of stake
  • Dec 3, 2025No plan
    Gtcr Fund Xi/a LP
    Large holder · sold 6,480,000 at $16.33
    $106M
    22% of stake
  • Nov 10, 2025No plan
    Warburg Pincus Private Equity Xi-C, L.p.
    Large holder · sold 18,000,000 at $15.65
    $282M
    29% of stake
  • Nov 10, 2025No plan
    Warburg Pincus Partners II, L.p.
    Large holder · sold 18,000,000 at $15.65
    $282M
    29% of stake
  • Nov 10, 2025No plan
    Gtcr Fund Xi/a LP
    Large holder · sold 12,000,000 at $15.65
    $188M
    29% of stake
  • Sep 5, 2025No plan
    Warburg Pincus Xi-C, LLC
    Large holder · sold 12,000,000 at $15.11
    $181M
    16% of stake
  • Sep 5, 2025No plan
    Warburg Pincus & CO.
    Large holder · sold 12,000,000 at $15.11
    $181M
    16% of stake
  • Sep 5, 2025No plan
    Gtcr Investment XI LLC
    Large holder · sold 8,000,000 at $15.11
    $121M
    16% of stake
  • Aug 22, 2025No plan
    Michael P Rutz
    President of Sterigenics · sold 126,611 at $16.38
    $2.07M
    22% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SHC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Misc Health & Allied Services, NEC

Spot a number that looks wrong? Check it in SHC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SHC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.